Retrospective Cohort Study
Copyright ©The Author(s) 2017.
World J Gastroenterol. Jan 28, 2017; 23(4): 614-621
Published online Jan 28, 2017. doi: 10.3748/wjg.v23.i4.614
Table 1 Patient characteristics n (%)
DBE negativeDBE positiveTotalP value
(n = 164)(n = 331)(n = 495)
Age at DBE, median (range)65.0 (18.1-95.4)69.5 (18.3-91.8)68.2 (18.1-95.4)0.0051
Gender0.1042
Male71 (43.3)169 (51.1)240 (48.5)
Female93 (56.7)162 (48.9)255 (51.5)
Altered anatomy0.7362
None125 (76.2)249 (75.2)374 (75.6)
Roux-en-Y13 (7.9)21 (6.3)34 (6.9)
Billroth/Ileo-colonic/IPAA7 (4.3)21 (6.3)28 (5.7)
Other19 (11.6)40 (12.1)59 (11.9)
On warfarin19 (11.6)36 (10.9)55 (11.1)0.8132
On clopidogrel7 (4.3)20 (6.0)27 (5.5)0.4132
On ASA 32549 (29.9)118 (35.6)167 (33.7)0.2012
VCE performed within 1 yr prior to DBE47 (29.4)130 (40.9)177 (36.9)
MPCTE performed within 1 yr prior to DBE31 (19.4)53 (16.7)84 (17.5)
VCE and MPCTE performed within 1 yr prior to DBE67 (41.9)113 (35.5)180 (37.8)
DBE performed without VCE and MPCTE done15 (9.4)22 (6.9)37 (7.7)
Type of OGIB0.7282
Overt82 (50.0)171 (51.7)253 (51.1)
Occult82 (50.0)160 (48.3)242 (48.9)
Type of approach of DBE< 0.0012
Anterograde103 (62.8)268 (81.0)371 (74.9)
Retrograde61 (37.2)63 (19.0)124 (25.1)
Total enteroscopy done9 (5.5)15 (4.5)24 (4.8)0.6412
Procedure location0.3932
Inpatient34 (20.7)80 (24.2)114 (23.0)
Outpatient130 (79.3)251 (75.8)381 (77.0)